Tag: Phthalazines

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Phthalazines

US FDA approves AstraZeneca cancer drug Lynparza for treatment of breast cancer | The ...

Added to Collection on: 2022-03-14 07:04:48

Tags for this article:

Cancer
Health
Organic compounds
Orphan drugs
Lactams
PARP inhibitors
Olaparib
Phthalazines
Hereditary cancers
Breast cancer
Prostate cancer
AstraZeneca
Merck
astrazeneca as

Click the tags to see associated articles and topics

View Article Details
Olaparib Market Size, Scope, Growth, Competitive Analysis – AstraZeneca, Everest ...

Added to Collection on: 2022-03-21 09:19:50

Tags for this article:

Market structure
Articles
Business
Economy
Business process
Lactams
Olaparib
Phthalazines
Market share
Market segmentation
Market research
Mintel

Click the tags to see associated articles and topics

View Article Details
AstraZeneca gets EU backing for targeted breast cancer therapies - SABC News

Added to Collection on: 2022-06-27 19:26:53

Tags for this article:

Life Sciences
Health care
Health sciences
Lactams
Olaparib
Phthalazines
AstraZeneca
Breast cancer
HER2/neu
Daiichi Sankyo
Cancer
Antibody-drug conjugate
Merck

Click the tags to see associated articles and topics

View Article Details
AstraZeneca gets EU backing for targeted breast cancer therapies - Market Screener

Added to Collection on: 2022-06-27 13:07:46

Tags for this article:

Health care
Health sciences
Drugs
Orphan drugs
Antibody-drug conjugates
Lactams
Olaparib
Phthalazines
AstraZeneca
Breast cancer
HER2/neu
Trastuzumab deruxtecan
Merck

Click the tags to see associated articles and topics

View Article Details
AstraZeneca and MSD's breast cancer drug Lynparza receives EC approval - PMLiVE

Added to Collection on: 2022-08-04 18:11:42

Tags for this article:

Cancer
Breast cancer
Clinical medicine
Health
Hereditary cancers
PARP inhibitors
Lactams
Olaparib
Phthalazines
BRCA mutation
Merck & Co.
BRCA1
AstraZeneca
United States

Click the tags to see associated articles and topics

View Article Details
Merck, AstraZeneca Net European Approval for Adjuvant Lynparza in BRCA-Mutated Early ...

Added to Collection on: 2022-08-04 15:51:50

Tags for this article:

Cancer
Organic compounds
Clinical medicine
Breast cancer
Lactams
Olaparib
Phthalazines
PARP inhibitor
BRCA1
Adjuvant therapy
Triple-negative breast cancer
Treatment of cancer
Merck
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
AstraZeneca and Merck Receives European Commission Approval For Expanded Use ... - Benzinga

Added to Collection on: 2022-08-04 15:21:34

Tags for this article:

Organic compounds
PARP inhibitors
Health care
Lactams
Olaparib
Phthalazines
Health
Cancer treatments
Merck & Co.
Breast cancer
HER2/neu
Triple-negative breast cancer
AstraZeneca
Merck Research Laboratories

Click the tags to see associated articles and topics

View Article Details
AstraZeneca breast cancer drug receives EU approval - Sharecast.com

Added to Collection on: 2022-08-04 15:15:27

Tags for this article:

Organic compounds
Life Sciences
Health sciences
Orphan drugs
Lactams
Olaparib
Phthalazines
Breast cancer
Cancer
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
DCGI approves AstraZeneca's Lynparza for adjuvant treatment of patients with high-risk ...

Added to Collection on: 2022-08-22 08:34:26

Tags for this article:

Hereditary cancers
Cancer
Breast cancer
Clinical medicine
Medicine
AstraZeneca
Olaparib
Phthalazines
BRCA mutation
Adjuvant therapy
BRCA
PARP inhibitor

Click the tags to see associated articles and topics

View Article Details
SOLO1: Olaparib Maintenance Continues to Provide Clinical Benefit at 7 Years

Added to Collection on: 2022-09-10 16:40:15

Tags for this article:

PARP inhibitors
Cancer
Lactams
AstraZeneca
Olaparib
Phthalazines
Companies
Health
RTT
Ovarian cancer
BRCA mutation

Click the tags to see associated articles and topics

View Article Details